Synthetic bone grafts, the role of the gypsum in bone substitution; molecular biological approach;A szintetikus csontpótló graftok alkalmazásának összefoglalása. A gipsz szerepe a csontpótlásban: Molekuláris biológiai megközelítéssel, saját eredményeink alapján

Orvosi Hetilap

Volumn 148, Issue 51, 2007, Pages 2427-2433

  Lazáry, Áron ^a,c   Balla, Bernadett ^a   Kósa, János ^a   Bácsi, Krisztián ^a   Nagy, Zsolt ^a   Takács, István ^a   Varga Péter, Pál ^b   Speer, Gábor ^a   Lakatos, Péter ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Országos Gerincgyógyászati Központ Budapest   (Hungary)

^c NONE   (Hungary)

Author keywords

Bone graft; Bone healing; Bone substitution; Gene; Gypsum; Osteoblast

Indexed keywords

ALKALINE PHOSPHATASE; BONE CEMENT; CALCIUM SULFATE; FILLER; POLY(METHYL METHACRYLATE);

ANIMAL CELL; ARTICLE; BIODEGRADABILITY; BONE CELL; BONE CONDUCTION; BONE GRAFT; CELL GROWTH; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GROWTH INHIBITION; LONG TERM CARE; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PATIENT SAFETY; SUBSTITUTION THERAPY;

EID: 38149141466     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2007.28020     Document Type: Article

References (36)

1. Peltier, L. F.: The use of plaster of Paris to fill defects in bone. Clin. Orthop., 1961, 21, 1.
2. Kelly, C. M., Wilkins, R. M., Gitelis, S. és mtsai: The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clin. Orthop. Relat. Res., 2001, 382, 42.
3. Borrelli, J., Jr., Prickett, W. D. Ricci, W. M.: Treatment of nonunions and osseous defects with bone graft and calcium sulfate. Clin. Orthop. Relat. Res., 2003, 411, 245.
4. Chen, W. J., Tsai, T. T., Chen, L. H. és mtsai: The fusion rate of calcium sulfate with local autograft bone compared with autologous iliac bone graft for instrumented short-segment spinal fusion. Spine, 2005, 30, 2293.
5. Silver, I. A., Murrills, R. J., Etherington, D. J.: Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp. Cell. Res., 1988, 175, 266.
6. 2+)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J. Bone Miner. Res., 1998, 13, 1530.
7. Yamauchi, M., Yamaguchi, T., Kaji, H. és mtsai: Involvement of calcium-sensing receptor in osteoblastic differentiation of mouse MC3T3-E1 cells. Am. J. Physiol. Endocrinol. Metab., 2005, 288, E608.
8. Nakade, O., Takahashi, K., Takuma, T. és mtsai: Effect of extracellular calcium on the gene expression of bone morphogenetic protein-2 and -4 of normal human bone cells. J. Bone Miner. Metab., 2001, 19, 13.
9. Giannoudis, P. V., Dinopoulos, H. Tsiridis, E.: Bone substitutes: an update. Injury, 2005, 36 Suppl 3, S20-27.
10. Van Heest, A. Swiontkowski, M.: Bone-graft substitutes. Lancet, 1999, 353 Suppl 1, S128-129.
11. Sandhu, H. S., Grewal, H. S., Parvataneni, H.: Bone grafting for spinal fusion. Orthop. Clin. North Am., 1999, 30, 685-698.
12. Arrington, E. D., Smith, W. J., Chambers, H. G. és mtsai: Complications of iliac crest bone graft harvesting. Clin. Orthop. Relat. Res., 1996, 300-309.
13. Boyce, T., Edwards, J. Scarborough, N.: Allograft bone. The influence of processing on safety and performance. Orthop. Clin. North Am., 1999, 30, 571-581.
14. Ehrler, D. M. Vaccaro, A. R.: The use of allograft bone in lumbar spine surgery. Clin. Orthop. Relat. Res., 2000, 38-45.
15. Tomford, W. W.: Transmission of disease through transplantation of musculoskeletal allografts. J. Bone Joint Surg., 1995, 77, 1742-1754.
16. Khan, S. N., Tomin, E. Lane, J. M.: Clinical applications of bone graft substitutes. Orthop. Clin. North Am., 2000, 31, 389-398.
17. Gazdag A. R., Lane, J. M., Glaser, D. és mtsai: Alternatives to Autogenous Bone Graft: Efficacy and Indications. JAAOS, 1995, 3, 1-8.
18. Kinnunen, L., Aitasalo, K., Pollonen, M. és mtsai: Reconstruction of orbital floor fractures using bioactive glass. J. Cranio-Max. Surg., 2000, 28, 229-234.
19. Peltola, M., Suonpaa, J., Aitasalo, K. és mtsai: Experimental follow-up model for clinical frontal sinus obliteration with bioactive glass (S53P4). Acta Oto-laryngol., 2000, 543, 167-169.
20. Chiu, R., Ma, T., Smith, R. L. és mtsai: Polymethyl-methacrylate particles inhibit osteoblastic differentiation of bone marrow osteoprogenitor cells. J. Biomed. Mater. Res. A., 2006, 77, 850.
21. Obrant, K. J., Ivaska, K. K., Gerdhem, P. és mtsai: Biochemical markers of bone turnover are influenced by recently sustained fracture. Bone, 2005, 36, 786.
22. Veitch, S. W., Findlay, S. C., Hamer, A. J. és mtsai: Changes in bone mass and bone turnover following tibial shaft fracture. Osteoporos. Int., 2006, 17, 364.
23. Sidqui, M., Collin, P., Vitte, C. és mtsai: Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate. Biomaterials, 1995, 16, 1327.
24. Winn, S. R., Hollinger, J. O.: An osteogenic cell culture system to evaluate the cytocompatibility of Osteoset, a calcium sulfate bone void filler. Biomaterials, 2000, 21, 2413.
25. Sowa, H., Kaji, H., Yamaguchi, T. és mtsai: Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells. J. Bone Miner. Res., 2002, 17, 1190.
26. Balooch, G., Balooch, M., Nalla, R. K. és mtsai: TGF-beta regulates the mechanical properties and composition of bone matrix. Proc. Natl. Acad. Sci. USA, 2005, 102, 18813.
27. Sugama, R., Koike, T, Imai, Y. és mtsai: Bone morphogenetic protein activities are enhanced by 3′,5′-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells. Bone, 2006, 38, 206.
28. Rundle, C. H., Wang, H., Yu, H. és mtsai: Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone, 2006, 38, 521.
29. Heiner, D. E., Meyer, M. H., Frick, S. L. és mtsai: Gene expression during fracture healing in rats comparing intramedullary fixation to plate fixation by DNA microarray. J. Orthop. Trauma, 2006, 20, 27.
30. Chiba, S., Okada, K., Lee, K. és mtsai: Molecular analysis of defect healing in rat diaphyseal bone. J. Vet. Med. Sci., 2001, 63, 603.
31. Corsi, A., Xu, T., Chen, X. D. és mtsai: Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Miner. Res., 2002, 17, 1180.
32. Coetzee, A. S.: Regeneration of bone in the presence of calcium sulfate. Arch. Otolaryngol., 1980, 106, 405.
33. Bucholz, R. W.: Nonallograft osteoconductive bone graft substitutes. Clin. Orthop. Relat. Res., 2002, 395, 44.
34. Tay, B. K., Patel, V. V., Bradford, D. S.: Calcium sulfate- and calcium phosphate-based bone substitutes. Mimicry of the mineral phase of bone. Orthop. Clin. North Am., 1999, 30, 615.
35. Hadjipavlou, A. G., Simmons, J. W., Yang, J. és mtsai: Plaster of Paris as an osteoconductive material for interbody vertebral fusion in mature sheep. Spine, 2000, 25, 10.
36. Walsh, W. R., Morberg, P., Yu, Y. és mtsai: Response of a calcium sulfate bone graft substitute in a confined cancellous defect. Clin. Orthop. Relat. Res., 2003, 406, 228.